G. Massa

2.6k total citations
77 papers, 1.8k citations indexed

About

G. Massa is a scholar working on Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G. Massa has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 28 papers in Molecular Biology and 28 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G. Massa's work include Growth Hormone and Insulin-like Growth Factors (23 papers), Sexual Differentiation and Disorders (20 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (19 papers). G. Massa is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (23 papers), Sexual Differentiation and Disorders (20 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (19 papers). G. Massa collaborates with scholars based in Belgium, Netherlands and Italy. G. Massa's co-authors include M Vanderschueren‐Lodeweyckx, Jan M. Wit, Liene Bervoets, P Malvaux, Margarita Craen, Claudine Heinrichs, Francis de Zegher, Jean De Schepper, M. Du Caju and L.T.M. Rekers-Mombarg and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, PEDIATRICS and Diabetologia.

In The Last Decade

G. Massa

76 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Massa Belgium 26 772 745 622 343 174 77 1.8k
Karen Rubin United States 16 1.0k 1.3× 630 0.8× 489 0.8× 254 0.7× 261 1.5× 32 1.9k
Margarita Craen Belgium 23 473 0.6× 523 0.7× 504 0.8× 530 1.5× 165 0.9× 72 1.8k
Roland Schweizer Germany 27 681 0.9× 620 0.8× 839 1.3× 411 1.2× 230 1.3× 88 1.8k
Markus Bettendorf Germany 27 657 0.9× 944 1.3× 1.3k 2.1× 328 1.0× 298 1.7× 117 2.4k
Berit Kriström Sweden 24 454 0.6× 515 0.7× 965 1.6× 473 1.4× 170 1.0× 61 1.6k
Daniel L. Metzger Canada 29 621 0.8× 649 0.9× 736 1.2× 223 0.7× 427 2.5× 82 2.5k
Claudine Heinrichs Belgium 30 907 1.2× 1.1k 1.5× 1.1k 1.7× 614 1.8× 269 1.5× 88 2.6k
John J. Chipman United States 19 578 0.7× 562 0.8× 1.4k 2.3× 391 1.1× 147 0.8× 34 1.8k
Jennifer Bell United States 20 348 0.5× 428 0.6× 523 0.8× 296 0.9× 145 0.8× 40 1.4k
P R Betts United Kingdom 25 465 0.6× 391 0.5× 652 1.0× 539 1.6× 219 1.3× 51 1.7k

Countries citing papers authored by G. Massa

Since Specialization
Citations

This map shows the geographic impact of G. Massa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Massa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Massa more than expected).

Fields of papers citing papers by G. Massa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Massa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Massa. The network helps show where G. Massa may publish in the future.

Co-authorship network of co-authors of G. Massa

This figure shows the co-authorship network connecting the top 25 collaborators of G. Massa. A scholar is included among the top collaborators of G. Massa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Massa. G. Massa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mandato, Claudia, Angelo Colucci, Roberta Lanzillo, et al.. (2023). Multiple Sclerosis—Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics. Children. 10(6). 1022–1022. 10 indexed citations
2.
Tripodi, M., Maria Siano, Claudia Mandato, et al.. (2017). Humanization of pediatric care in the world: focus and review of existing models and measurement tools. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 43(1). 76–76. 14 indexed citations
3.
Zegers, Doreen, Sigri Beckers, Rik Hendrickx, et al.. (2013). Mutation screen of the SIM1 gene in pediatric patients with early-onset obesity. International Journal of Obesity. 38(7). 1000–1004. 19 indexed citations
4.
Vajro, Pietro, et al.. (2013). Pediatric non alcoholic fatty liver disease: more on novel treatment targets. BMC Pediatrics. 13(1). 109–109. 4 indexed citations
5.
Doggen, Kris, Dominique Beckers, Kristina Casteels, et al.. (2012). Care delivery and outcomes among Belgian children and adolescents with type 1 diabetes. European Journal of Pediatrics. 171(11). 1679–1685. 7 indexed citations
6.
7.
Vanderfaeillie, Johan, Muriel Thomas, G. Massa, et al.. (2007). Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age. European Journal of Endocrinology. 156(2). 195–201. 16 indexed citations
8.
Thomas, Muriel, G. Massa, Dominique Beckers, et al.. (2003). Growth Hormone (GH) Secretion in Patients with Childhood-Onset GH Deficiency: Retesting after One Year of Therapy and at Final Height. Hormone Research in Paediatrics. 59(1). 7–15. 32 indexed citations
9.
Binder, Gerhard, et al.. (2001). Isolated GH Deficiency with Dominant Inheritance: New Mutations, New Insights. The Journal of Clinical Endocrinology & Metabolism. 86(8). 3877–3881. 60 indexed citations
10.
Thomas, Muriel, G. Massa, J P Bourguignon, et al.. (2001). Final Height in Children with Idiopathic Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone: The Belgian Experience. Hormone Research in Paediatrics. 55(2). 88–94. 38 indexed citations
11.
Broeck, Jan Van den, et al.. (2000). Length Velocity Acceleration at 9 Months of Age in a Representative Birth Cohort of Dutch Infants. Journal of Pediatric Endocrinology and Metabolism. 13(1). 45–54. 6 indexed citations
12.
Rekers-Mombarg, L.T.M., et al.. (1999). Influence of Growth Hormone Treatment on Pubertal Timing and Pubertal Growth in Children with Idiopathic Short Stature. Journal of Pediatric Endocrinology and Metabolism. 12(5). 611–22. 24 indexed citations
13.
Rekers-Mombarg, L.T.M., G. Massa, J.M. Wit, et al.. (1998). Growth hormone therapy with three dosage regimens in children with idiopathic short stature. The Journal of Pediatrics. 132(3). 455–460. 32 indexed citations
14.
Massa, G., et al.. (1997). Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate). European Journal of Pediatrics. 156(10). 792–794. 59 indexed citations
15.
Massa, G., B.J. Otten, M. Jansen, et al.. (1995). Treatment with Two Growth Hormone Regimens in Girls with Turner Syndrome: Final Height Results. Hormone Research. 43(4). 144–146. 34 indexed citations
16.
17.
Massa, G., Francis de Zegher, & M Vanderschueren‐Lodeweyckx. (1992). Serum Levels of Immunoreactive Inhibin, FSH, and LH in Human Infants at Preterm and Term Birth. Neonatology. 61(3). 150–155. 39 indexed citations
18.
Massa, G. & M Vanderschueren‐Lodeweyckx. (1991). Age and Height at Diagnosis in Turner Syndrome: Influence of Parental Height. PEDIATRICS. 88(6). 1148–1152. 37 indexed citations
19.
Massa, G., M Vanderschueren‐Lodeweyckx, Margarita Craen, M. Vandeweghe, & Guy Van Vliet. (1991). Growth hormone treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests. European Journal of Pediatrics. 150(7). 460–463. 7 indexed citations
20.
Proesmans, Willem, G. Massa, & M Vanderschueren‐Lodeweyckx. (1988). Growth from birth to adulthood in a patient with the neonatal form of bartter syndrome. Pediatric Nephrology. 2(2). 205–209. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Rubin Breakdown of academic impact, for papers by Margarita Craen Breakdown of academic impact, for papers by Roland Schweizer Breakdown of academic impact, for papers by Markus Bettendorf Breakdown of academic impact, for papers by Berit Kriström Breakdown of academic impact, for papers by Daniel L. Metzger Breakdown of academic impact, for papers by Claudine Heinrichs Breakdown of academic impact, for papers by John J. Chipman Breakdown of academic impact, for papers by Jennifer Bell Breakdown of academic impact, for papers by P R Betts
Rankless by CCL
2026